secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2024-01-02T23:59:59+00:00
Accession:  0001104659-24-000140
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco names Lawrence Kurzius next Chairman; proposes board declassification and majority voting
--------------------------------------------------------------------------------

- Lawrence Kurzius to become Chairman after 2024 annual meeting; R. David Hoover remains on board.
- Board to declassify, grant shareholders rights to amend bylaws and call special meetings.
- Company to seek approval to change director elections from plurality to majority of votes cast.
- Post-meeting: Michael Harrington to chair Corporate Governance, Kirk McDonald to chair Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465924000140/0001104659-24-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465924000140/tm2334009d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer